Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endovascular Treatment of Patients in China With the Surpass Streamline Flow Diverter for Unruptured Large and Giant Saccular Wide-Neck or Fusiform Intracranial Aneurysms in the Internal Carotid Artery

NCT05544045 is registered in ClinicalTrials.gov with Stryker Neurovascular as lead sponsor.

NCT NCT05544045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05544045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endovascular Treatment of Patients in China With the Surpass Streamline Flow Diverter for Unruptured Large and Giant Saccular Wide-Neck or Fusiform Intracranial Aneurysms in the Internal Carotid Artery
Lead sponsor
Stryker Neurovascular
Phase
Observational
Overall status
Terminated
Start date
June 3, 2022
Completion date
September 30, 2023
Enrollment
11 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysm, intracranial